EMILY RUSSELL: Open Payments
NPI 1699701540 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 13 payments from 7 companies in 2025. Trend: 2023 $284 · 2024 $493 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $274 |
| Neurocrine BioSciences, Inc. | 1 | $140 |
| ABBVIE INC. | 2 | $113 |
| Lilly USA, LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: Wegovy, INGREZZA, QULIPTA, Ozempic, MOUNJARO, TRELEGY ELLIPTA, Rybelsus, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
